Compared with the AKI group, levels of HO‐1 (Figure 2G) and KIM‐1 (Figure 2H) in the HAND group returned to normal, demonstrating far superior therapeutic effects compared to the CND group, while the NAC group showed negligible therapeutic benefit. This evidence concerns the gene HMOX1 and acute kidney injury.